The following is a summary of “Effect of spesolimab on sustained disease control in patients with generalized pustular ...

Two new drugs to treat prostate and liver cancer have been given the green light for use by the NHS in Scotland. The Scottish ...

TWO new medicines have been approved to help treat prostate and liver cancer patients in Scotland. The Scottish Medicines ...

The Scottish Medicines Consortium has approved two new drugs for use with patients via the NHS. Two new medicines have been ...

Patients with generalized pustular psoriasis experienced flares despite the use of traditional off-label therapies and frequently changed treatment.

Boehringer Ingelheim announced new analyses to be presented at the American Academy of Dermatology (AAD) annual meeting in Orlando that explore the effect that SPEVIGO® (spesolimab-sbzo) may have on ...

Generalized pustular psoriasis (GPP) is a serious and rare form of psoriasis that can cause systemic symptoms. Because GPP can be life threatening, hospitalization may be necessary when a flare ...

In 2024 the SMC accepted several other cancer drugs including dabrafenib, known by the brand name Finlee, for use in combination with trametinib (Spexotras), for treating children aged one and older ...

Generalized pustular psoriasis (GPP) is considered a rare and severe form of psoriasis that may be treated with a combination of oral medications, topical treatments, and more. Generalized ...

Generalized pustular psoriasis (GPP) can range in severity and may be life threatening for some people. Treatment typically includes a variety of topical, oral, and injectable medications.

Generalized Pustular Psoriasis Market Outlook 2025-2035: The 7 major generalized pustular psoriasis market reached a value of USD 19.6 Billion in 2024. Looking forward, IMARC Group expects the 7MM to ...

Promising signs from a vaccination trial should greatly interest producers with breeder herds looking to avoid virgin bulls ...